Follow the people · Insider
Jennifer Kayden Lee
Jennifer Kayden Lee files insider transactions with the SEC as an evp, head of north america of Rhythm Pharmaceuticals (RYTM). We hold 1 disclosed purchase or sale filed since 4 February 2020, 1 of them in the last 90 days.
- Files forRYTM
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure14 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 9 November 2020 — 13 August 2026EVP, Head of North America · Rhythm Pharmaceuticals (RYTM)111 Form 4 lines · source: SEC Form 4
- Filed 31 January 2020 — 31 January 2020Chief Commercial Officer · Krystal Biotech (KRYS)1 Form 4 line · source: SEC Form 4
Everything they disclosed
112 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 35,000 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- exercised options over 21,601 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- ▼ sold on the open market 75,834 shares of Rhythm PharmaceuticalsSEC Form 414 August 2026Common Stock · traded 13 August 2026 · filed 14 August 2026
- exercised options over 35,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 414 August 2026Stock Options (Right to Buy) · traded 13 August 2026 · filed 14 August 2026
- exercised options over 21,601 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 414 August 2026Stock Options (Right to Buy) · traded 13 August 2026 · filed 14 August 2026
- was granted 21,650 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- was granted 32,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Options (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- was granted 21,650 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Restricted Stock Units · traded 11 February 2026 · filed 13 February 2026
- was granted 32,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2026Stock Options (Right to Buy) · traded 11 February 2026 · filed 13 February 2026
- exercised options over 22,612 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- had shares withheld for tax on 9,237 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- exercised options over 3,437 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 3,437 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 4,512 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 5,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 9,163 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 4,512 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 5,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 9,163 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2026Restricted Stock Units · traded 1 February 2026 · filed 3 February 2026
- exercised options over 22,612 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- had shares withheld for tax on 9,237 shares of Rhythm PharmaceuticalsSEC Form 43 February 2026Common Stock · traded 1 February 2026 · filed 3 February 2026
- was granted 36,650 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 14 February 2025 · filed 19 February 2025
- was granted 55,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Stock Options (Right to Buy) · traded 14 February 2025 · filed 19 February 2025
- exercised options over 5,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 5,500 shares of Rhythm PharmaceuticalsSEC Form 419 February 2025Common Stock · traded 16 February 2025 · filed 19 February 2025
- ▼ sold on the open market 2,035 shares of Rhythm PharmaceuticalsSEC Form 419 February 2025Common Stock · traded 19 February 2025 · filed 19 February 2025
- ▼ sold on the open market 600 shares of Rhythm PharmaceuticalsSEC Form 414 February 2025Common Stock · traded 12 February 2025 · filed 14 February 2025
- ▼ sold on the open market 10 shares of Rhythm PharmaceuticalsSEC Form 414 February 2025Common Stock · traded 12 February 2025 · filed 14 February 2025
- ▼ sold on the open market 1,205 shares of Rhythm PharmaceuticalsSEC Form 414 February 2025Common Stock · traded 12 February 2025 · filed 14 February 2025
- ▼ sold on the open market 1,205 shares of Rhythm PharmaceuticalsSEC Form 414 February 2025Common Stock · traded 13 February 2025 · filed 14 February 2025
- exercised options over 3,437 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2025Restricted Stock Units · traded 9 February 2025 · filed 11 February 2025
- exercised options over 4,189 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2025Stock Option (Right to Buy) · traded 9 February 2025 · filed 11 February 2025
- exercised options over 2,031 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2025Restricted Stock Units · traded 11 February 2025 · filed 11 February 2025
- exercised options over 3,437 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 9 February 2025 · filed 11 February 2025
- exercised options over 4,189 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 9 February 2025 · filed 11 February 2025
- ▼ sold on the open market 1,894 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 10 February 2025 · filed 11 February 2025
- ▼ sold on the open market 2,295 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 10 February 2025 · filed 11 February 2025
- exercised options over 2,031 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 11 February 2025 · filed 11 February 2025
- ▼ sold on the open market 1,023 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 11 February 2025 · filed 11 February 2025
- ▼ sold on the open market 4 shares of Rhythm PharmaceuticalsSEC Form 411 February 2025Common Stock · traded 11 February 2025 · filed 11 February 2025
- ▼ sold on the open market 1,733 shares of Rhythm PharmaceuticalsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- ▼ sold on the open market 1,133 shares of Rhythm PharmaceuticalsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- ▼ sold on the open market 200 shares of Rhythm PharmaceuticalsSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- exercised options over 4,513 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 44 February 2025Restricted Stock Units · traded 1 February 2025 · filed 4 February 2025
- exercised options over 4,513 shares of Rhythm PharmaceuticalsSEC Form 44 February 2025Common Stock · traded 1 February 2025 · filed 4 February 2025
- ▼ sold on the open market 1,447 shares of Rhythm PharmaceuticalsSEC Form 44 February 2025Common Stock · traded 4 February 2025 · filed 4 February 2025
- exercised options over 20,622 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (Right to Buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 28,717 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (Right to Buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 11,642 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2024Stock Option (Right to Buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 20,622 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- exercised options over 28,717 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- exercised options over 11,642 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 38,051 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 17,540 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 11,070 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 200 shares of Rhythm PharmaceuticalsSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 9,169 shares of Rhythm PharmaceuticalsSEC Form 422 March 2024Common Stock · traded 20 March 2024 · filed 22 March 2024
- ▼ sold on the open market 9,066 shares of Rhythm PharmaceuticalsSEC Form 422 March 2024Common Stock · traded 20 March 2024 · filed 22 March 2024
- ▼ sold on the open market 15,515 shares of Rhythm PharmaceuticalsSEC Form 419 March 2024Common Stock · traded 19 March 2024 · filed 19 March 2024
- was granted 22,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- was granted 67,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 421 February 2024Stock Option (Right to Buy) · traded 16 February 2024 · filed 21 February 2024
- was granted 33,750 shares of Rhythm PharmaceuticalsSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- exercised options over 3,438 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Restricted Stock Units · traded 9 February 2024 · filed 13 February 2024
- exercised options over 2,031 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2024Restricted Stock Units · traded 11 February 2024 · filed 13 February 2024
- exercised options over 3,438 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 9 February 2024 · filed 13 February 2024
- exercised options over 2,031 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 11 February 2024 · filed 13 February 2024
- ▼ sold on the open market 1,023 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 12 February 2024 · filed 13 February 2024
- ▼ sold on the open market 615 shares of Rhythm PharmaceuticalsSEC Form 413 February 2024Common Stock · traded 13 February 2024 · filed 13 February 2024
- exercised options over 4,513 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 45 February 2024Restricted Stock Units · traded 1 February 2024 · filed 5 February 2024
- exercised options over 4,513 shares of Rhythm PharmaceuticalsSEC Form 45 February 2024Common Stock · traded 1 February 2024 · filed 5 February 2024
- ▼ sold on the open market 1,492 shares of Rhythm PharmaceuticalsSEC Form 45 February 2024Common Stock · traded 1 February 2024 · filed 5 February 2024
- exercised options over 12,030 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 November 2023Stock Option (Right to Buy) · traded 14 November 2023 · filed 16 November 2023
- exercised options over 12,030 shares of Rhythm PharmaceuticalsSEC Form 416 November 2023Common Stock · traded 14 November 2023 · filed 16 November 2023
- ▼ sold on the open market 13,677 shares of Rhythm PharmaceuticalsSEC Form 416 November 2023Common Stock · traded 14 November 2023 · filed 16 November 2023
- exercised options over 5,712 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2023Stock Option (Right to Buy) · traded 8 November 2023 · filed 13 November 2023
- exercised options over 3,438 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 November 2023Stock Option (Right to Buy) · traded 9 November 2023 · filed 13 November 2023
- exercised options over 5,712 shares of Rhythm PharmaceuticalsSEC Form 413 November 2023Common Stock · traded 8 November 2023 · filed 13 November 2023
- ▼ sold on the open market 3,479 shares of Rhythm PharmaceuticalsSEC Form 413 November 2023Common Stock · traded 8 November 2023 · filed 13 November 2023
- ▼ sold on the open market 2,233 shares of Rhythm PharmaceuticalsSEC Form 413 November 2023Common Stock · traded 8 November 2023 · filed 13 November 2023
- exercised options over 3,438 shares of Rhythm PharmaceuticalsSEC Form 413 November 2023Common Stock · traded 9 November 2023 · filed 13 November 2023
- ▼ sold on the open market 1,719 shares of Rhythm PharmaceuticalsSEC Form 413 November 2023Common Stock · traded 9 November 2023 · filed 13 November 2023
- ▼ sold on the open market 1,719 shares of Rhythm PharmaceuticalsSEC Form 413 November 2023Common Stock · traded 9 November 2023 · filed 13 November 2023
- exercised options over 80 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 47 November 2023Stock Option (Right to Buy) · traded 3 November 2023 · filed 7 November 2023
- exercised options over 80 shares of Rhythm PharmaceuticalsSEC Form 47 November 2023Common Stock · traded 3 November 2023 · filed 7 November 2023
- ▼ sold on the open market 80 shares of Rhythm PharmaceuticalsSEC Form 47 November 2023Common Stock · traded 3 November 2023 · filed 7 November 2023
- exercised options over 4,519 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 47 September 2023Stock Option (Right to Buy) · traded 5 September 2023 · filed 7 September 2023
- exercised options over 4,519 shares of Rhythm PharmaceuticalsSEC Form 47 September 2023Common Stock · traded 5 September 2023 · filed 7 September 2023
- ▼ sold on the open market 6,166 shares of Rhythm PharmaceuticalsSEC Form 47 September 2023Common Stock · traded 5 September 2023 · filed 7 September 2023
- exercised options over 8,591 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 49 August 2023Stock Option (Right to Buy) · traded 7 August 2023 · filed 9 August 2023
- exercised options over 1,718 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 49 August 2023Stock Option (Right to Buy) · traded 9 August 2023 · filed 9 August 2023
- exercised options over 8,591 shares of Rhythm PharmaceuticalsSEC Form 49 August 2023Common Stock · traded 7 August 2023 · filed 9 August 2023
- ▼ sold on the open market 11,223 shares of Rhythm PharmaceuticalsSEC Form 49 August 2023Common Stock · traded 7 August 2023 · filed 9 August 2023
- exercised options over 1,718 shares of Rhythm PharmaceuticalsSEC Form 49 August 2023Common Stock · traded 9 August 2023 · filed 9 August 2023
- ▼ sold on the open market 1,718 shares of Rhythm PharmaceuticalsSEC Form 49 August 2023Common Stock · traded 9 August 2023 · filed 9 August 2023
- ▼ sold on the open market 1,204 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 9 February 2023 · filed 14 February 2023
- exercised options over 2,031 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 414 February 2023Restricted Stock Units · traded 11 February 2023 · filed 14 February 2023
- exercised options over 2,031 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 11 February 2023 · filed 14 February 2023
- ▼ sold on the open market 635 shares of Rhythm PharmaceuticalsSEC Form 414 February 2023Common Stock · traded 14 February 2023 · filed 14 February 2023
- exercised options over 3,438 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 413 February 2023Restricted Stock Units · traded 9 February 2023 · filed 13 February 2023
- exercised options over 3,438 shares of Rhythm PharmaceuticalsSEC Form 413 February 2023Common Stock · traded 9 February 2023 · filed 13 February 2023
- ▼ sold on the open market 1,192 shares of Rhythm PharmaceuticalsSEC Form 413 February 2023Common Stock · traded 9 February 2023 · filed 13 February 2023
- was granted 18,050 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2023Restricted Stock Units · traded 1 February 2023 · filed 3 February 2023
- was granted 46,900 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 43 February 2023Stock Option (Right to Buy) · traded 1 February 2023 · filed 3 February 2023
- exercised options over 2,032 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 415 February 2022Restricted Stock Units · traded 11 February 2022 · filed 15 February 2022
- exercised options over 2,032 shares of Rhythm PharmaceuticalsSEC Form 415 February 2022Common Stock · traded 11 February 2022 · filed 15 February 2022
- ▼ sold on the open market 722 shares of Rhythm PharmaceuticalsSEC Form 415 February 2022Common Stock · traded 15 February 2022 · filed 15 February 2022
- was granted 13,750 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2022Restricted Stock Units · traded 9 February 2022 · filed 11 February 2022
- was granted 82,500 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 411 February 2022Stock Option (Right to Buy) · traded 9 February 2022 · filed 11 February 2022
- was granted 8,125 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 February 2021Restricted Stock Units · traded 11 February 2021 · filed 16 February 2021
- was granted 48,750 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 416 February 2021Stock Option (Right to Buy) · traded 11 February 2021 · filed 16 February 2021
- was granted 100,000 shares of Rhythm Pharmaceuticals (a derivative holding)SEC Form 410 November 2020Stock Option (Right to Buy) · traded 9 November 2020 · filed 10 November 2020
- was granted 125,000 shares of Krystal Biotech (a derivative holding)SEC Form 44 February 2020Stock Option (Right to Buy) · traded 31 January 2020 · filed 4 February 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.